Replimune Group Statistics
Total Valuation
Replimune Group has a market cap or net worth of EUR 605.56 million. The enterprise value is 441.92 million.
| Market Cap | 605.56M |
| Enterprise Value | 441.92M |
Important Dates
The last earnings date was Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 82.57M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +22.99% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 3.96% |
| Owned by Institutions (%) | 76.60% |
| Float | 61.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.38 |
| P/TBV Ratio | 3.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.65 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.83 |
Financial Position
The company has a current ratio of 5.60, with a Debt / Equity ratio of 0.36.
| Current Ratio | 5.60 |
| Quick Ratio | 5.43 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.27 |
| Interest Coverage | -40.70 |
Financial Efficiency
Return on equity (ROE) is -90.88% and return on invested capital (ROIC) is -47.94%.
| Return on Equity (ROE) | -90.88% |
| Return on Assets (ROA) | -43.24% |
| Return on Invested Capital (ROIC) | -47.94% |
| Return on Capital Employed (ROCE) | -114.36% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -559,834 |
| Employee Count | 479 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -356,011 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.80% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -42.80% |
| 50-Day Moving Average | 6.93 |
| 200-Day Moving Average | 6.49 |
| Relative Strength Index (RSI) | 62.95 |
| Average Volume (20 Days) | 503 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 10.56 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -276.14M |
| Pretax Income | -268.52M |
| Net Income | -268.16M |
| EBITDA | -271.59M |
| EBIT | -276.14M |
| Earnings Per Share (EPS) | -2.93 |
Balance Sheet
The company has 229.22 million in cash and 65.02 million in debt, with a net cash position of 164.20 million.
| Cash & Cash Equivalents | 229.22M |
| Total Debt | 65.02M |
| Net Cash | 164.20M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 179.32M |
| Book Value Per Share | 2.25 |
| Working Capital | 196.12M |
Cash Flow
In the last 12 months, operating cash flow was -236.70 million and capital expenditures -4.56 million, giving a free cash flow of -241.26 million.
| Operating Cash Flow | -236.70M |
| Capital Expenditures | -4.56M |
| Free Cash Flow | -241.26M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Replimune Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.99% |
| Shareholder Yield | -22.99% |
| Earnings Yield | -44.28% |
| FCF Yield | -39.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |